Ravidasvir
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
Synonyms | PPI-668 |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C42H50N8O6 |
Molar mass | 762.91 g·mol−1 |
3D model (JSmol) | |
| |
|
Ravidasvir (PPI-668) is an investigational NS5A inhibitor in clinical trials for chronic hepatitis C genotype 4.[1]
Preliminary clinical trial results were announced in Nov 2015.[2]
See also
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.